Chantemele EJ, Csányi G. Identification of novel macropinocytosis inhibitors using a rational screen of Food

and Drug Administration-approved drugs. Br J of Pharmacol, 2018 Sep. (IF: 9.47)

3. Singla B

*

, Lin HP

*

, Ahn W, White J, Csányi G. Oxidatively Modified LDL Suppresses

Lymphangiogenesis via CD36 Signaling. Antioxidants (Basel). 2021 Feb. (IF: 7.67)

4. Singla B, Lin HP, Ahn W, Xu J, Ma Q, Sghayyer M, Dong K, Cherian-Shaw M, Zhou J, Huo Y,

White J, Csányi G. Loss of myeloid cell-specific SIRPα, but not CD47, attenuates inflammation and

suppresses atherosclerosis. Cardiovasc Res. 2021 Dec. (IF: 10.79)

5. Singla B, Lin HP, Chen A, Ahn W, Ghoshal P, Cherian-Shaw M, White J, Stansfield BK, Csányi G.

Role of R-spondin 2 in arterial lymphangiogenesis and atherosclerosis. Cardiovasc Res. 2021 May. (IF:

8. Singla B, Ghoshal P, Lin HP, Wei Q, Dong Z, and Csanyi G. PKCdelta mediates fluid-phase

macropinocytosis of allergens by immature dendritic cells. Front Immunol. 2018 Mar 26. (IF: 8.78)

9. Csanyi G, Csanyi G, Feck DM, Ghoshal P, Singla B, Lin HP, Nagarajan S, Meijles DN, Al Ghouleh

I, Cantu-Medellin NC, Kelley EE, Mateuszuk LM, Isenberg JS, Watkins SC, Pagano PJ. CD47 and Nox1

Mediate Dynamic Fluid-Phase Macropinocytosis of Native LDL. Antioxid Redox Signal. 2016 Dec. (IF:

8.40)

10. Ghoshal P, Singla B, Lin HP, Feck DM, Cantu-Medellin N, Kelley EE, Haigh S, Fulton D, and

Csanyi G. Nox2-mediated PI3K and Cofilin Activation Confers Alternate Redox Control of Macrophage

Pinocytosis. Antioxid Redox Signal. 2016 Aug. (IF: 8.40)